PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 1, 2024Microbial Biotechnology4 citationsOpen Access

Identification of a potent PCNA‐p15‐interaction inhibitor by autodisplay‐based peptide library screening

View Full Paper
SHSarah HardebeckNGNatalie Jácobo GoebbelsCMCaroline Michalski

Key Points

Key points are not available for this paper at this time.

Abstract

Abstract Proliferating cell nuclear antigen (PCNA) is an essential factor for DNA metabolism. The influence of PCNA on DNA replication and repair, combined with the high expression rate of PCNA in various tumours renders PCNA a promising target for cancer therapy. In this context, an autodisplay‐based screening method was developed to identify peptidic PCNA interaction inhibitors. A 12‐mer randomized peptide library consisting of 2.54 × 10 6 colony‐forming units was constructed and displayed at the surface of Escherichia coli BL21 (DE3) cells by autodisplay. Cells exhibiting an enhanced binding to fluorescent mScarlet‐I‐PCNA were enriched in four sorting rounds by flow cytometry. This led to the discovery of five peptide variants with affinity to mScarlet‐I‐PCNA. Among these, P3 (TCPLRWITHDHP) exhibited the highest binding signal. Subsequent flow cytometric analysis revealed a dissociation constant of 0.62 μM for PCNA‐P3 interaction. Furthermore, the inhibition of PCNA interactions was investigated using p15, a PIP‐box containing protein involved in DNA replication and repair. P3 inhibited the PCNA‐p15 51‐70 interaction with a half maximal inhibitory activity of 16.2 μM, characterizing P3 as a potent inhibitor of the PCNA‐p15 interaction.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Hardebeck et al. (2024) studied this question.

synapsesocial.com/papers/68e70ef4b6db6435876884bdhttps://doi.org/10.1111/1751-7915.14471
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Abstract 6583: Developing a selective cancer chemotherapy by small molecule-based targeting of PCNA protein2024
  2. 2Abstract 5124: Identification and structural characterization of a novel PCNA-interacting small molecule scaffold2026
  3. 3Abstract 5784: Structure-based drug design against caPCNA for selective cancer chemotherapy development2024
  4. 4Targeting proliferating cell nuclear antigen enhances ionizing radiation‐induced cytotoxicity in prostate cancer cells2024 · 2 citations
  5. 5Targeting PCNA in Cancer: A Paradigm Shift from Static Inhibition to Dynamic Network Modulation2026